Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về vaccine COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 14/1 đến ngày 21/1/2022. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.
SCIENCEDIRECT
1. Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional study
American Journal of Infection Control, 28 October 2021, Volume 50, Issue 1 (Cover date: January 2022), Pages 8-14
Renuka Ananth Kalyan Kadali, Ravali Janagama, Isha Shah
https://www.sciencedirect.com/science/article/pii/S019665532100688X/pdfft?md5=336c568cb4796ebd4d433d0493abd7cf&pid=1-s2.0-S019665532100688X-main.pdf
2. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
EBioMedicine, 21 December 2021, Volume 75 (Cover date: January 2022), Article 103762
Runhong Zhou, Pui Wang, Zhiwei Chen
https://www.sciencedirect.com/science/article/pii/S2352396421005569/pdfft?md5=e38a7932e23a3ed673cd39c94aa80085&pid=1-s2.0-S2352396421005569-main.pdf
3. Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
Multiple Sclerosis and Related Disorders, 2 December 2021, Volume 57 (Cover date: January 2022), Article 103433
Samantha Epstein, Zongqi Xia, Sarah F. Wesley
https://www.sciencedirect.com/science/article/pii/S2211034821006994/pdfft?md5=df64c2fd062ee53bee7c4beadd5cace3&pid=1-s2.0-S2211034821006994-main.pdf
4. Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination
Biosensors and Bioelectronics, 8 December 2021, Volume 199 (Cover date: 1 March 2022), Article 113868
Liping Huang, Ying Li, Gang L. Liu
https://www.sciencedirect.com/science/article/pii/S0956566321009052/pdfft?md5=861e33898d1a2232afb17dd0f58535b9&pid=1-s2.0-S0956566321009052-main.pdf
5. BCG vaccination and the risk of COVID 19: A possible correlation
Virology, 28 October 2021, Volume 565 (Cover date: 2 January 2022), Pages 73-81
Sara M. Ahmed, Mohamed A. Nasr, Nagwa El-Badri
https://www.sciencedirect.com/science/article/pii/S004268222100204X/pdfft?md5=e914fa14342fe9dae209fe75167462c8&pid=1-s2.0-S004268222100204X-main.pdf
6. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
Placenta, 6 December 2021, Volume 117 (Cover date: January 2022), Pages 161-168
Sudha Warrier, S Mohana Sundaram, Ananthakrishnan
https://www.sciencedirect.com/science/article/pii/S0143400421006548/pdfft?md5=3cb2431dbe26c34a34cfe20b0a48b64a&pid=1-s2.0-S0143400421006548-main.pdf
7. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
The Lancet Infectious Diseases, 1 September 2021, Volume 22, Issue 1 (Cover date: January 2022), Pages 43-55
Michela Antonelli, Rose S Penfold, Claire J Steves
https://www.sciencedirect.com/science/article/pii/S1473309921004606/pdfft?md5=1293676d58ec9e3f8e671d256028a04f&pid=1-s2.0-S1473309921004606-main.pdf
8. Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273
Journal of Virological Methods, 23 September 2021, Volume 299 (Cover date: January 2022), Article 114297
Alexander Krüttgen, Maike Lauen, Michael Kleines
https://www.sciencedirect.com/science/article/pii/S0166093421002366/pdfft?md5=97f75be49f5220e1c240a29ceac4390b&pid=1-s2.0-S0166093421002366-main.pdf
9. Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt
Infection, Genetics and Evolution, 17 December 2021, Volume 97 (Cover date: January 2022), Article 105191
Mohamed G. Seadawy, Ahmed F. Gad, Mervat G. Hassan
https://www.sciencedirect.com/science/article/pii/S1567134821004913/pdfft?md5=66c7f0c12a88b9dc708721a0e14a7f45&pid=1-s2.0-S1567134821004913-main.pdf
10. Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers
Journal of Infection and Public Health, 24 December 2021, Volume 15, Issue 2 (Cover date: February 2022), Pages 182-186
Pragya D. Yadav, Prasad Sarkale, Sreelekshmy Mohandas
https://www.sciencedirect.com/science/article/pii/S1876034121004299/pdfft?md5=cfd0e1732c375b56d6e518063334c4be&pid=1-s2.0-S1876034121004299-main.pdf
11. A peptide-based assay discriminates individual antibody response to SARS-CoV-2
Genes & Diseases, 5 February 2021, Volume 9, Issue 1 (Cover date: January 2022), Pages 275-281
Immacolata Polvere, Serena Voccola, Tiziana Zotti
https://www.sciencedirect.com/science/article/pii/S2352304221000155/pdfft?md5=b3bdef2c14e6d55deccf77d1f4b3d371&pid=1-s2.0-S2352304221000155-main.pdf
12. Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
Journal of Immunological Methods, 8 November 2021, Volume 500 (Cover date: January 2022), Article 113182
Luciana Villafañe, Lucía Gallo Vaulet, Fabiana Bigi
https://www.sciencedirect.com/science/article/pii/S0022175921002271/pdfft?md5=3483a03d08e13534c786b8321ffe1003&pid=1-s2.0-S0022175921002271-main.pdf
13. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations
Infection, Genetics and Evolution, 18 November 2021, Volume 97 (Cover date: January 2022), Article 105153
William M. Showers, Sonia M. Leach, Michael Strong
https://www.sciencedirect.com/science/article/pii/S1567134821004536/pdfft?md5=79771f9adc07586ea84e53fe87396a02&pid=1-s2.0-S1567134821004536-main.pdf
14. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
International Journal of Infectious Diseases, 22 October 2021, Volume 114 (Cover date: January 2022), Pages 165-174
Michiko Asano, Hiroshi Okada, Johan Vekemans
https://www.sciencedirect.com/science/article/pii/S1201971221008183/pdfft?md5=59afa092f89e0005ae7a3a6157a89172&pid=1-s2.0-S1201971221008183-main.pdf
WILEY
1. Anti-SARS-CoV-2 spike protein and neutralizing antibodies at one and 3 months after 3 doses of SARS-CoV-2 vaccine in a large cohort of solid-organ-transplant patients
Nassim Kamar, Florence Abravanel, Olivier Marion, Laure Esposito, Anne Laure Hebral, Chloé Médrano, Joelle Guitard, Laurence Lavayssière, Olivier Cointault, Marie Bétriace Nogier, Julie Bellière, Stanislas Faguer, Chloé Couat, Arnaud Del Bello, Jacques Izopet
American Journal of TransplantationAccepted Articles
First published: 09 January 2022
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajt.16950
2. INDUCTION OF HUMORAL AND CELLULAR IMMUNE RESPONSES TO COVID-19 mRNA AND VECTOR VACCINES: A PROSPECTIVE COHORT STUDY IN BULGARIAN HEALTHCARE WORKERS
Maria Nikolova, Yana Todorova, Radoslava Emilova, Iva Trifonova, Teodora Gladnishka, Nina Petrova-Yancheva, Tatyana Chervenyakova, Elena Dragusheva, Georgi Popov, Iva Christova
Journal of Medical VirologyAccepted Articles
First published: 07 January 2022
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27572
3. Managing the risk of COVID-19 via vaccine passports: Modeling economic and policy implications
Rajeev K. Goel, James R. Jones
Managerial and Decision EconomicsEarly View
First published: 09 January 2022
https://onlinelibrary.wiley.com/doi/epdf/10.1002/mde.3546
4. Attitudes Towards Influenza and Pneumococcal Vaccines in Parents of Asthmatic Children During the COVID-19 Pandemic
Murat Özer, Nevzat Başkaya, İlknur Bostancı
Pediatric PulmonologyAccepted Articles
First published: 08 January 2022
https://onlinelibrary.wiley.com/doi/epdf/10.1002/ppul.25818
5. Global sharing of COVID-19 vaccines: A duty of justice, not charity
Nancy S. Jecker
Developing World BioethicsEarly View
First published: 08 January 2022
https://onlinelibrary.wiley.com/doi/epdf/10.1111/dewb.12342
PUBMED
1. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan.
Saita M, Yan Y, Ito K, Sasano H, Seyama K, Naito T.J Infect Chemother. 2022 Jan;28(1):116-119. doi: 10.1016/j.jiac.2021.09.009. Epub 2021 Sep 16.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443338/pdf/main.pdf
2. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study.
Rottenstreich M, Sela HY, Rotem R, Kadish E, Wiener-Well Y, Grisaru-Granovsky S.BJOG. 2022 Jan;129(2):248-255. doi: 10.1111/1471-0528.16941. Epub 2021 Oct 6.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652528/pdf/BJO-9999-0.pdf
3. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, Chamberlin G, Fathy R, Nazarian RM, Desai SR, Lim HW, Thiers BH, Hruza GJ, French LE, Blumenthal K, Fox LP, Freeman EE.J Am Acad Dermatol. 2022 Jan;86(1):113-121. doi: 10.1016/j.jaad.2021.09.002. Epub 2021 Sep 10.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431833/pdf/main.pdf
4. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D, O'Ryan M, Torres JP, Zuniga M, Santelices E, Basso LJ.Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428469/pdf/main.pdf
5. COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity.
Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M, Sorkin JD, Lal BK.Ann Surg. 2022 Jan 1;275(1):31-36. doi: 10.1097/SLA.0000000000005176.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678152/pdf/ansu-275-0031.pdf
6. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, Gao L, Yu Q, Lam ICH, Chun RKC, Cowling BJ, Fong WC, Lau AYL, Mok VCT, Chan FLF, Lee CK, Chan LST, Lo D, Lau KK, Hung IFN, Leung GM, Wong ICK.Lancet Infect Dis. 2022 Jan;22(1):64-72. doi: 10.1016/S1473-3099(21)00451-5. Epub 2021 Aug 16.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367195/pdf/main.pdf
7. Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography.
Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB.Radiology. 2022 Jan;302(1):84-87. doi: 10.1148/radiol.2021211374. Epub 2021 Aug 17.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488809/pdf/radiol.2021211374.pdf
8. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
Hunjan MK, Roberts C, Karim S, Hague J.Clin Exp Dermatol. 2022 Jan;47(1):188-190. doi: 10.1111/ced.14878. Epub 2021 Sep 24.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444918/pdf/CED-9999-0.pdf
SPRINGER NATURE
1. Association of vitamin D status with COVID-19 and its severity
Jae Hyun Bae, Hun Jee Choe… in Reviews in Endocrine and Metabolic Disorde… (2022)
https://link.springer.com/content/pdf/10.1007%2Fs11154-021-09705-6.pdf
2. No substantial excess all-cause mortality among cardiac implantable electronic device patients during the first COVID‑19 lockdown in the Leiden area
M. Feijen, A. D. Egorova, E. T. van der Velde, M. J. Schalij… in Netherlands Heart Journal (2022)
https://link.springer.com/content/pdf/10.1007%2Fs12471-021-01650-y.pdf
3. Epidemiological Control of COVID-19 Through the Theory of Variable Structure and Sliding Mode Systems
Débora Marques Lopes Santos… in Journal of Control, Automation and Electri… (2022)
https://link.springer.com/content/pdf/10.1007%2Fs40313-021-00826-6.pdf
4. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms
Xuhuan Tang, Fang Zheng in Neurological Sciences (2022)
https://link.springer.com/content/pdf/10.1007%2Fs10072-021-05679-0.pdf
5. COVID-19: a look into the modern age pandemic
Mohammad Aadil Qamar in Journal of Public Health (2022)
https://link.springer.com/content/pdf/10.1007%2Fs10389-020-01294-z.pdf
Các công bố về COVID-19 trước thời gian trên:
Cập nhật các công bố về COVID-19 từ ngày 7/1 đến ngày 14/1/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html
Cập nhật các công bố về COVID-19 từ ngày 1/1 đến ngày 7/1/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html
Nguồn: Cục Thông tin KH&CN Quốc gia, 21/1/2021
